Compare CNTX & SORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTX | SORA |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | Hong Kong |
| Employees | N/A | 7 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 47.0M |
| IPO Year | 2021 | N/A |
| Metric | CNTX | SORA |
|---|---|---|
| Price | $0.62 | $1.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 18.2K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $1.25 |
| 52 Week High | $3.62 | $7.20 |
| Indicator | CNTX | SORA |
|---|---|---|
| Relative Strength Index (RSI) | 30.62 | 37.38 |
| Support Level | $0.55 | N/A |
| Resistance Level | $0.70 | $2.14 |
| Average True Range (ATR) | 0.06 | 0.33 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 40.14 | 34.92 |
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
AsiaStrategy is a wholesaler engaged in trading, distribution, and retail of luxury watches of international brands. The Group sources its luxury watches from Europe, Singapore, Japan, and Hong Kong, then sells the goods to retail sellers and other distributors in the watch industry.